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Background: The compatibility study of active substances with excipients finds an important role in the domain of
pharmaceutical research, being known the fact that final formulation is the one administered to the patient. In
order to evaluate the compatibility between active substance and excipients, different analytical techniques can be
used, based on their accuracy, reproducibility and fastness.
Results: Compatibility study of two well-known active substances, procaine and benzocaine, with four commonly
used excipients, was carried out employing thermal analysis (TG/DTG/HF) and Fourier Transform Infrared
Spectroscopy (UATR-FT-IR). The selected excipients were microcrystalline cellulose, lactose monohydrate,
magnesium stearate and talc. Equal proportion of active substance and excipients (w/w) was utilized in the
interaction study. The absolute value of the difference between the melting point peak of active substances and
the one corresponding for the active substances in the analysed mixture, as well the absolute value of the
difference between the enthalpy of the pure active ingredient melting peak and that of its melting peak in the
different analysed mixtures were chosen as indexes of the drug-excipient interaction degree. All the results
obtained through thermal analysis were also sustained by FT-IR spectroscopy.
Conclusions: The corroboration of data obtained by thermal analysis with the ones from FT-IR spectroscopy
indicated that no interaction occurs between procaine and benzocaine, with microcrystalline cellulose and talc, as
well for the benzocaine-lactose mixture. Interactions were confirmed between procaine and benzocaine
respectively and magnesium stearate, and for procaine and lactose.
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Before or during the development of solid dosage
forms, large scale development trials are normally pre-
ceded by the evaluation of possible interactions be-
tween a drug and different excipients used in the
formulation process. Although, excipients are required
to be medically inert, physical and chemical interac-
tions with the active substance can occur. The screen-
ing of a novel excipient for possible incompatibilities is
therefore an absolute requirement [1,2].
The humidity and temperature can generate interac-
tions between a drug and an excipient. The drug-
excipient interactions can affect drug dissolution and/or
bioavailability or/and their therapeutic efficacy and
safety. The mechanisms by which the excipients affect
the stability of drug are chemical reactions, sorption of
moisture, and/or catalysis. Hence, the choice of excipi-
ents by carrying out systemic study is very important.
Thermal analytical methods are used for the determin-
ation of physical properties, kinetic properties, poly-
morphic forms and transitions, product stability, and
excipient compatibility [3-5].
DSC, respectively DTA/HF had been shown to be an
important method for the preliminary phase of any
preformulation study of solid dosage form to quickly
detect the interactions by comparing the thermal curves
obtained for the active substance, for the excipients, and
for their physical mixtures.
From the appearance, shift or disappearance of endo-
thermic/exothermic peaks and/or variations in the cor-
responding enthalpy values in thermal curves of drug–
excipient mixtures, it can be prove the existence of a
possible interaction between the active substance and
the excipient used.
A number of techniques have been used for screening
of drug–excipient mixtures for interactions or incompat-
ibilities including isothermal stress testing and thermal
analysis [4,5]. Thermal analysis has the advantage over
conventional isothermal stress testing in that long term
storage of physical mixtures and chromatographic
analysis are not required and only a few milligrams of
sample is needed [4,6-8]. However, the technique has
been criticized as being inconclusive because the mois-
ture stress testing is usually not included and the
temperature ranges, which are used, are not characteris-
tic of normal storage conditions.
Even if it’s considered a “stepping stone” in formula-
tion, compatibility testing provide only an approximate
indication for the selection/deselection of excipients, as
the final composition of the pharmaceutical formulation
is usually different from the one tested in the compati-
bility study [9,10].
FT-IR spectroscopy is a simple, fast and an accurate
technique for the evaluation of changes which occurduring active substance - excipient mixing. The use of
FT-IR relies in the analysis of spectra, by the dis-
appearance of an absorption band, modification of
its intensity or position (shifting to lower/higher
wavenumbers). Also, the appearance of new absorption
bands is an indisputable argument that suggests an ac-
tive substance-excipient interaction. The use of spec-
troscopic methods, such as FTIR can bring valuable
information about the mechanism of interaction, by
the assignment of the bands that appear or disappear
in the mixture’s spectra, comparative to the ones for
active substance and excipient. Compared to classic
FTIR spectroscopy, where the spectra acquisition is
usually carried out on a pressed-dispersion of sample
in KBr, UATR-FT-IR technique provides superior data
quality combined with high reproducibility and has
some advantages including: fastness, as no preparation
of the samples is required, neither for the active sub-
stance, the excipient or their mixture; it is non-
destructive and requires small quantities of sample
which can be recovered from the surface of the spec-
trometer’s crystal after the analysis; Also, it’s accuracy
is sustained by the fact that in case of classic FTIR
sample preparation, the use of a mechanical press to
form the pellet can induce interactions that normally
does not occur in the formulation step, despite the fact
that the sample is considered diluted due to the pres-
ence of KBr [10].
Combining DSC, respectively DTA/HF technique with
a technique such as Fourier Transform Infrared (FT-IR)
Spectroscopic analysis, as complementary tool, allows
for detail understanding, elucidation, and interpretation
of potential interactions at the molecular level.
Procaine (4-aminobenzoic acid 2-(diethyl-amino)ethyl
ester, Novocain) is a local anaesthetic of the ester
type which is hydrolysed in vivo to produce para-
aminobenzoic acid, which inhibits the action of sulfon-
amides. Procaine is absorbed following parenteral
administration, and can be used in combination with va-
soconstrictors in order to prolong its action. Pharma-
ceutical administration forms contain usually 0.25 to
0.5% procaine for infiltration anaesthesia, 0.5 to 2.0% for
peripheral nerve block and 10% for spinal block [11].
Procaine is used as well in analgesic, geriatric and anti-
viral formulations [12].
Benzocaine (4-aminobenzoic acid ethyl ester) is con-
sidered an anaesthetic of “low solubility”. This class of
agents can be applied directly on injured skin and ulcer-
ated surfaces, where they remain localized for long pe-
riods of time to produce a prolonged anaesthetic action.
Benzocaine is incorporated into a large number of top-
ical preparations [11] for local anaesthesia, such as den-
tal sprays, ear medication or in throat anaesthetic
lozenges [13] and as a desensitizer in condoms [14].
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patibility study of the selected active substances, namely
procaine (PR) and benzocaine (BZ) and four excipients
of common use for sustained release have not been
reported earlier, to our knowledge.
For this purpose, simultaneous TG/DSC measure-
ments and UATR-FT-IR spectroscopy measurements
were carried out on each of the components, both in the
pure form and the corresponding 1:1 (w/w) physical
mixtures. The absolute value of the difference between
the melting endothermic peak temperature of pure drug
and that in each analysed mixture and the absolute value
of the difference between the enthalpy of the pure active
ingredient melting peak and that of its melting peak in
the different analysed mixtures were chosen as indexes
of the drug-excipient interaction degree. As well, the




The active ingredients, procaine chlorohydrate (PR) and
benzocaine (BZ), were obtained from Sigma Chemical
Co (lot No. 34D1214) and have an analytical purity.
Excipients tested were: magnesium stearate (MS) (Union
Derivan Spain), talc powder (T) (Luzenac Pharma Italy),
microcrystalline cellulose (MC) (ParChem Trading
Israel) and lactose monohydrate (L) (Grain Processing
Corporation USA). All the compounds have an analytical
purity and were used as received, without further
purification.
The mixed samples consisted of equal masses of active
substance and each excipient. Physical mixtures were
prepared in proportion (w/w) 1:1 (active substance:
excipient) by simple mixing of the two substances in an
agate mortar with pestle for approximately 5 minutes.
The 1:1 (w/w) ratio was chosen in order to maximize
the probability of observing any interaction.
Thermal analysis was completed using a simultaneous
TG/DTA instrument from Perkin-Elmer DIAMOND.
The experiments were carried out using aluminium
crucibles with approximately 7–8 mg of the sample. For
determination of the heat effects, the DTA curves
(in μV · mg−1) were changed with the Heat Flow curves
(in mW mg−1), so that the peak area corresponds to an
energy in J g−1 or kJ mol−1. The experiments were com-
pleted in an air atmosphere at a flow rate of 100 mL
min-1. These were performed under non-isothermal con-
ditions by increasing temperature from ambient up to
500°C, at a heating rate β = 7°C min-1.
The IR spectra were carried out using a Perkin Elmer
SPECTRUM 100 device in the range of 4000-600 cm-1
on an UATR device, with 16 acquisitions for each
spectrum.In order to evaluate the accuracy of the measurements,
three repetitions have been done with this experimental
protocol for the samples and the obtained results were
comparable.
Results and discussion
Thermal behaviour of the two active substances
Thermal behaviour of active substances was studied and
presented in a previous paper [15]. In order to compare
the TG/DTG and HF curves obtained for PR and BZ
(active substances) with the ones for active substance-
excipient mixture, the first are presented in Figure 1, but
at a heating rate β = 7°C min-1.
As mentioned in our previous paper [15], thermal de-
composition of PR in an air atmosphere occurs in one
single process and begins at 196.64°C, as presented in
Figure 1. The decomposition occurs in the temperature
range 196.6-351.5°C, with the mass loss of 83.57% and
Tpeak DTG = 278.8°C.
The HF curve of procaine at β = 7°C min-1 presents, for
beginning, a sharp endothermic peak at 155.8°C (Tonset =
142.8°C; ΔHfus = 110.462 J⋅g
-1) indicating the melting and
which corresponds to the values indicated in literature
(155-156°C). In this temperature range, it can’t be ob-
served a mass loss on the TG/DTG curves. This process
of melting is followed by another two events: the first one
is an endothermic process at 279.9°C (Tonset = 238.3°C;
ΔHfus = 243.31 J⋅g
-1) and the last one has an exothermic
nature with a maximum at 342.6°C (Tonset = 302.8°C;
ΔHfus = −144.79 J⋅g
-1).
In the case of benzocaine, the thermal behaviour is
similar. The first thermal event for the BZ is an endo-
thermic one, without mass loss, and represents the melt-
ing of this active substance (HFpeak = 90.1°C; Tonset =
76.23°C; ΔHfus = 107.94 J⋅g
-1). This value is the same with
the melting point mentioned in literature (88-90°C). The
following thermal event take place in the temperature range
135.9-247°C with a mass loss percentage Δm=99.9%
(HFpeak = 245.2°C). The experimental determined values for
the thermal parameters are similar to the ones obtained in
our previous study [15], the differences being attributed to
a different heating rate (β = 7°C ·min-1, instead of β = 10°C ·
min-1) (see Table 1).
Compatibility study with the excipients by thermal
analysis
The DSC and thermogravimetrical curves of individual
excipients which were used in the compatibility study
are presented in Figure 2.
The thermoanalytical curves for the analyzed mixtures
(binary systems: active substance + excipient) are presented
in Figure 3.
The thermal curves of benzocaine and procaine re-
spectively, MC and their physical mixture (Figure 3 (a)
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any changes in the values of the process’ temperatures
(Tonset ot Tpeak), nor disappearance and appearance of
supplementary peaks in the case of the mixtures with
MC. The melting behaviour of the drugs (PR and BZ) is
not affected by the presence of MC. It may be concluded
that there is no interaction between the two active sub-
stances and MC under the testing conditions.
Another used excipient is talc, which possess a higher
thermal stability, as can be seen in Figure 2 (c). According
to V. Balek et al. [16], the first mass loss for a sample
of talc is observed by TG in the range 900-1050°C
and characterized the loss of structural water due toFigure 1 The thermoanalytical curves TG/DTG/HF obtained in air at βdehydroxylation of Mg3Si4O10(OH)2 and accompanied by
the formation of enstatite (MgSiO3) and silica [17].
As expected, in the thermoanalytical curves of talc, no
peaks were observed in the analysed range 50-550°C
(Figure 2 (c)). For the two mixtures with this excipient,
the endothermic peak which corresponds to the melting
process of PR and BZ, respectively was well preserved at
154 and 88°C, respectively in the HF curve of the active
substance-talc mixture.
The thermoanalytical curves of magnesium stearate (Fig-
ure 2 (a)) present a lot of thermal events. The HF curve of
this excipient shows three principal events: the first corres-
pond to the dehydration process from range 75-102°C; the= 7°C min-1 for the analysed active substances: (a) BZ and (b) PR.
Table 1 Thermoanalytical data of the two active
substances and the used excipients































78; 362 50 117 dehydratation;
decomposition
Talc -- -- -- -- --
Figure 2 TG/DTG/HF curves in air at 7°C min–1 for: (a) magnesium ste
microcrystalline cellulose (MC).
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http://journal.chemistrycentral.com/content/7/1/140second event (119-130°C) indicates the melting point for
palmitic acid salt and stearic acid salt with magnesium, re-
spectively [18], being known that pharmaceutical MS used
as excipient is a mixture of different magnesium salts of
some fatty acids, the mainly proportions being the salts of
stearic and palmitic acid. Being a mixture, this excipient
melts in an extent temperature range which can vary be-
tween 117 and 150°C, but a high purity form of this excipi-
ent was reported having the melting at 128 ± 2°C [19].
The HF curves of benzocaine and procaine, respect-
ively with magnesium stearate reveals a well-defined
interaction with this excipient which were evidenced by
the shift of the endothermic melting peaks with more
than 2°C compared to that of pure active substance.
Due to the comparison of the TG/DTG/HF curves of
the two active substances, MS and their binary mixtures,
it can be concluded that the stability of the analysedarate (MS); (b) lactose monohydrate (L); (c) talc (T); (d)
Figure 3 The TG/DTG/HF for the binary mixture of the two active substances (BZ and PR) with different excipients: (a) BZ + L; (b)
BZ +MC; (c) BZ +MS; (d) BZ + T; (e) PR + L; (f) PR +MC; (g) PR +MS; (h) PR + T.
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Thus, it can be said that this excipient increased the
thermal degradation of procaine. The TG curve of the
1:1 (w:w) binary mixture between PR and MS, shown in
Figure 3 (g), when compared to the TG curve of the
pure PR and to the TG curve of the pure MS (shown in
Figures 1 and 2(a)), confirms the reaction between the
drug and the excipient, evidenced by the premature
mass loss. The thermal decomposition begins at a lower
temperature value (Tonset DTG = 163°C for the mixture
with MS) and the maximum of DTG peak takes place at
259°C. Another reason for an accelerated degradation is
the value of Δm (%) which is greater than 50%, the
expected value due to the fact that the mixture is in pro-
portion (w/w) 1:1. Given these changes, the thermal sta-
bility of PR in the presence of MS was reduced, due to
the possible chemical interaction between the active sub-
stances and excipient under heating. In the case of BZ
mixture with MS, the thermal degradation of the active
substance begins at a higher temperature value (Tonset
DTG = 137°C) and the value for the melting temperature
is increased with ≈ 25°C.
The same thing was noticed in the HF curve of the
binary mixture of procaine with lactose monohydrate
(Figure 3 (f )) that presented a shift of the procaine’ melt-
ing peak from 144 to 154°C suggesting a drug-excipient
interaction upon mixing and heating treatment. Another
difference consists in the fact that the DSC patterns of
the binary mixture of PR with lactose monohydrate
showed peaks which occurred at different temperature
in addition to those recorded for the individual sub-
stances (Table 2). It can be seen from this table that in
the case of PR-L mixture, an additional prominent DTG
peak appeared at Tpeak DTG = 191°C (Tonset = 142°C) and
the main DTG peak at Tonset = 190°C in the case of pureTable 2 Thermoanalytical data of active substances and their
Samples HF ΔHf
Tonset (fusion)/°C Tpeak (fusion)/°C
Active substance
BZ 77;147 90;246
PR 148; 240 156; 279
Drug/excipient
BZ +MC 84; 161; 309 90; 204; 327
BZ + L 77; 153 88; 196
BZ + MS 103 113.5
BZ + T 78; 159 88; 222
PR +MC 146 154
PR + L 114 144
PR + MS 133 149
PR + T 144; 219 154; 263; 288PR degradation shifted to higher temperature of Tonset =
226°C, probably due to the interaction of lactose mono-
hydrate with this active substance.
The values of Tpeak, Tonset for DTG and HF curves, the
mass loss percentage (Δm) and the heat of fusion value
(ΔHf ) of melting event of procaine and benzocaine re-
spectively, in various excipient mixtures, are presented
in Table 2.Compatibility study with the excipients by UATR-FT-IR
spectroscopy
The FT-IR spectra of excipients (Figure 4a), and the
ones of active substances (PR and BZ) superposed with
the studied mixtures (Figure 4b-e) are presented in order
to confirm the interaction previously mentioned.
By the analysis of FTIR spectrum of pure PR, one can
notice the presence of several distinctive bands, character-
istic to vibrational modes of functional groups, as follows:
a doublet consisting of two sharp N-H stretching bands at
3345 and 3314 cm-1, a –NH2 scissoring band at 1604 cm
-1
and -NH2 wagging and twisting bands in the 850-750 cm
-1
spectral range. The band around 3200 cm-1 can be assigned
to ammonium ions (due to the fact that procaine was used
as a chlorohydrate) The spectrum also shows a C-N
stretching band in 1360-1250 cm-1 range characteristic for
aromatic amines. The presence of a tertiary amino group is
sustained by the -N-CH2 stretching band around 1170 cm
-1.
The two most polar bonds in esters are the C =O and C-O
respectively, which produce distinctive bands in the
spectrum around 1700 cm-1 and 1200 cm-1, respectively. Be-
ing an aromatic ester, it is expected that aromatic C =O
stretching appears at lower wavenumbers than the ones
characteristic for aliphatic ones (which absorb near
1750 cm-1), in this case at 1692 cm-1. On the other hand,physical mixtures
usion/J g
–1 DTG Δm /%
Tonset /°C Tpeak DTG/°C
107.95 130 241 99.9
110.47 194.5 281 90
50.23 110 201 55; 45
48.52 87; 122 99; 195; 226 3; 52
37.18 137 227 5; 50
54.70 120 220 50
50.89 173; 266 247; 280 65
29.35 142; 226 191; 278 50
32.12 163 259 70
56.78 180 273 45
Figure 4 FT-IR spectra of: pure excipients (a); PR and BZ with MC (b); PR and BZ with L (c); PR and BZ with MS (d); PR and BZ with T (e).
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around 1250 cm-1 [20].
The similarity of benzocaines’ structure to the one of
procaine lead to the conclusion that IR spectra presents
several similarities, namely: a doublet consisting of two
sharp N-H stretching bands at 3340 and 3320 cm-1, a –
NH2 scissoring band at 1594 cm
-1 and NH2 waging and
twisting bands in the 850-750 cm-1 spectral range. The
spectrum also shows a C-N stretching band in 1366-
1240 cm-1 range characteristic for aromatic amines. The
C =O and C-O bonds in an aromatic ester produce dis-
tinctive bands at 1679 cm-1 and 1253 cm-1, respectively.
The FTIR bands characteristic to C-C, C-H or aro-
matic ring does not present interest in our study due tothe fact that in formulation step, their breaking is highly
improbable. According to this, the analysis of FTIR spec-
tra will be focused on the modification of characteristic
bands for N-H and carbonyl groups.
The analysis of BZ and PR mixtures with MC
Characteristic vibration bands for functional groups
(amine, ester) for both active substances can be identi-
fied even in the FTIR spectrum of mixtures. No bands
suffer modification of intensity or shifting to increased
or decreased wavenumbers. The FTIR spectra of PR
and BZ mixtures with MC show the presence of the
characteristic band for the O-H stretching of hydroxyls
from MC at 3450 cm-1 as a broad signal. The C = O
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the case of pure PR and BZ. In this case, FTIR
spectroscopy confirms that no interaction occurs
(Figure 4b).The analysis of BZ and PR mixtures with L
By comparative analysis of FTIR spectrum for BZ and
BZ + L, once can notice that no alteration of the spectra
occurs. It can be considered that the spectrum of BZ + L
mixture is a superposing of both BZ and L spectra, lead-
ing to the conclusion that no interaction occurs. On the
other hand, surprisingly, the spectrum of PR + L mixture
is different than the superposition of the ones for pure
compounds. As can be seen, the characteristic O-H
stretching from lactose around 3550 cm-1 disappear, as
well the band characteristic for ammonium ion from
procaine (3200 cm-1). By the FTIR spectroscopy
analysis one can confirm that no interaction occurs
between BZ and L, but an incompatibility occurs for
PR + L mixture. A tentative explanation for the inter-
action of procaine with lactose can be attributed to the
fact that under heating, procaine hydrochloride de-
composes with the release of HCl. It is known that lac-
tose is a disaccharide derived from the condensation of
galactose with glucose, by a β-1→ 4 glycosidic linkage.
The presence of HCl creates an acidic medium, which
can lead to lactose hydrolysis with the formation of the
corresponding monosaccharides or their degradation
products.The analysis of BZ and PR mixtures with MS
MS is the only excipient from the ones’ studied that is
incompatible with both active substances. Pure MS pre-
sents two intense absorption bands at 1566 cm-1 and
1466 cm-1, respectively, corresponding to asymmetric
stretch of the COO- anion, and at higher wavenumber
(2917 cm-1 and 2850 cm-1) the ones corresponding to vi-
brations of C-H bonds. The analysis of FTIR spectra lead
to the conclusion that the main modification in the mo-
lecular structure of both PR and BZ took place at ester
carboxyl moiety. In both cases, a significant shifting of
bands to higher wavenumbers occurs. In the case of
PR +MS, the wavenumber is shifted up to 1722 cm-1,
and for BZ +MS, is shifted up to 1730 cm-1. Literature
indicates that stretching of aliphatic C =O occurs in
spectral range 1750-1730 cm-1 [20]. In this case, a pos-
sible explanation for this shifting could be the fact that
the esteric group suffers a chemical modification, with
the transformation of the aromatic ester into an aliphatic
one due to the presence of stearate anion or leading to
the formation of p-aminobenzoic acid, due to the hy-
drolysis of ester by the presence of HCl. Surprisingly, in
the FTIR spectra of mixtures, bands corresponding toCOO- anion from MS still appears, leading to the con-
clusion a part of MS remains unmodified in the mixture.
The analysis of BZ and PR mixtures with T
For both mixtures, PR +T and BZ+T, the FTIR spectra can
be considered as a superposition of the individual ones with-
out modification of bands’ characteristics. The FTIR spectrum
of T contains fewer bands than the ones of other excipients,
due to the fact that has a simple structure comparative to the
ones of organic molecules. The main bands that appear in
the FTIR spectrum of T are the ones at 3675 cm-1 (stretching
vibration of O-H bond from Si-O-H moiety), at 1050 cm-1
(stretching vibration of O-Si bond from Si-O-H moiety) and
at 675 cm-1 and 525 cm-1 (asymmetrical vibrations for Si–O
bond) [20]. In the case of binary mixtures, the bands appear
unmodified compared to pure T. On the other hand, no
modifications are noticed for the bands corresponding to PR
and BZ. It can be stated that both active substances are com-
patible withTand no interaction occurs.
Conclusions
The results obtained from this study confirm that the
thermoanalytical methods (TG/DTG/HF) and FTIR
spectroscopy can be used as simple and accurate
methods in the evaluation of the compatibility between
PR and BZ respectively and the four tested excipients.
No interaction was observed between procaine and benzo-
caine, with microcrystalline cellulose and talc, as well for the
BZ+L mixture. This fact is confirmed by FTIR spectroscopy
were nor disappearance or appearance of supplementary
bands in the case of the mixtures with MC, T and L. It may
be concluded that there is no interaction between the two
active substances (PR and BZ) and MC and T under the
testing conditions, nor for BZ and L.
From the results of the Heat Flow and thermogravimetrical
studies, an interaction was confirmed between PR and BZ re-
spectively and MS, and for PR and L. All these experimental
observations are sustained by the use of UATR-FT-IR spec-
troscopy as a complementary tool for compatibility testing.
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